202 related articles for article (PubMed ID: 21161615)
1. Alterations of the B-cell response by HIV-1 replication.
Shen X; Tomaras GD
Curr HIV/AIDS Rep; 2011 Mar; 8(1):23-30. PubMed ID: 21161615
[TBL] [Abstract][Full Text] [Related]
2. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
3. Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines.
Kang CY; Gao Y
AIDS Res Ther; 2017 Sep; 14(1):47. PubMed ID: 28893272
[TBL] [Abstract][Full Text] [Related]
4. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504
[TBL] [Abstract][Full Text] [Related]
5. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
6. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
[TBL] [Abstract][Full Text] [Related]
7. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
8. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H
J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.
Bonsignori M; Moody MA; Parks RJ; Holl TM; Kelsoe G; Hicks CB; Vandergrift N; Tomaras GD; Haynes BF
J Immunol; 2009 Aug; 183(4):2708-17. PubMed ID: 19625640
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.
Monini P; Cafaro A; Srivastava IK; Moretti S; Sharma VA; Andreini C; Chiozzini C; Ferrantelli F; Cossut MR; Tripiciano A; Nappi F; Longo O; Bellino S; Picconi O; Fanales-Belasio E; Borsetti A; Toschi E; Schiavoni I; Bacigalupo I; Kan E; Sernicola L; Maggiorella MT; Montin K; Porcu M; Leone P; Leone P; Collacchi B; Palladino C; Ridolfi B; Falchi M; Macchia I; Ulmer JB; Buttò S; Sgadari C; Magnani M; Federico MP; Titti F; Banci L; Dallocchio F; Rappuoli R; Ensoli F; Barnett SW; Garaci E; Ensoli B
PLoS One; 2012; 7(11):e48781. PubMed ID: 23152803
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.
Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM
Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443
[TBL] [Abstract][Full Text] [Related]
12. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
[TBL] [Abstract][Full Text] [Related]
13. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.
Choi J; Walker J; Boichuk S; Kirkiles-Smith N; Torpey N; Pober JS; Alexander L
J Virol; 2005 Jan; 79(1):264-76. PubMed ID: 15596822
[TBL] [Abstract][Full Text] [Related]
14. High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence.
Wang Y; Sundling C; Wilson R; O'Dell S; Chen Y; Dai K; Phad GE; Zhu J; Xiao Y; Mascola JR; Karlsson Hedestam GB; Wyatt RT; Li Y
J Immunol; 2016 May; 196(9):3729-43. PubMed ID: 27001953
[TBL] [Abstract][Full Text] [Related]
15. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.
Zheng N; Fujiwara M; Ueno T; Oka S; Takiguchi M
J Virol; 2009 Aug; 83(15):7668-77. PubMed ID: 19457989
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
17. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.
Moir S; Ho J; Malaspina A; Wang W; DiPoto AC; O'Shea MA; Roby G; Kottilil S; Arthos J; Proschan MA; Chun TW; Fauci AS
J Exp Med; 2008 Aug; 205(8):1797-805. PubMed ID: 18625747
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.
Li W; Li C; Xia W; Li X
Hum Vaccin Immunother; 2017 Oct; 13(10):2341-2347. PubMed ID: 28771107
[TBL] [Abstract][Full Text] [Related]
19. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
20. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
Churchyard GJ; Morgan C; Adams E; Hural J; Graham BS; Moodie Z; Grove D; Gray G; Bekker LG; McElrath MJ; Tomaras GD; Goepfert P; Kalams S; Baden LR; Lally M; Dolin R; Blattner W; Kalichman A; Figueroa JP; Pape J; Schechter M; Defawe O; De Rosa SC; Montefiori DC; Nabel GJ; Corey L; Keefer MC;
PLoS One; 2011; 6(8):e21225. PubMed ID: 21857901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]